Knipe D, Padmanathan P, Newton-Howes G, Chan LF, Kapur N (2022) Suicide and self-harm. Lancet 399(10338):1903–1916

Article  PubMed  Google Scholar 

Liu RT, Walsh RFL, Sheehan AE, Cheek SM, Sanzari CM (2022) Prevalence and correlates of suicide and nonsuicidal self-injury in children: a systematic review and meta-analysis. JAMA Psychiat. https://doi.org/10.1001/jamapsychiatry.2022.1256

Article  Google Scholar 

Turecki G, Brent DA (2016) Suicide and suicidal behaviour. Lancet 387(10024):1227–1239

Article  PubMed  Google Scholar 

Fu TS, Lee CS, Gunnell D, Lee WC, Cheng AT (2013) Changing trends in the prevalence of common mental disorders in Taiwan: a 20-year repeated cross-sectional survey. Lancet 381(9862):235–241

Article  PubMed  Google Scholar 

Chang YH, Lin CY, Liao SC, Chen YY, Shaw FF, Hsu CY et al (2022) Societal factors and psychological distress indicators associated with the recent rise in youth suicide in Taiwan: a time trend analysis. Aust N Z J Psychiatry. https://doi.org/10.1177/00048674221108640

Article  PubMed  Google Scholar 

Abbar M, Demattei C, El-Hage W, Llorca PM, Samalin L, Demaricourt P et al (2022) Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial. BMJ 376:e067194

Article  PubMed  PubMed Central  Google Scholar 

Price RB, Kissel N, Baumeister A, Rohac R, Woody ML, Ballard ED et al (2022) International pooled patient-level meta-analysis of ketamine infusion for depression: in search of clinical moderators. Mol Psychiatry. https://doi.org/10.1038/s41380-022-01757-7

Article  PubMed  PubMed Central  Google Scholar 

Kritzer MD, Mischel NA, Young JR, Lai CS, Masand PS, Szabo ST et al (2022) Ketamine for treatment of mood disorders and suicidality: a narrative review of recent progress. Ann Clin Psychiatry 34(1):33–43

PubMed  PubMed Central  Google Scholar 

Evers AG, Murrough JW, Charney DS, Costi S (2022) Ketamine as a prophylactic resilience-enhancing agent. Front Psych 13:833259

Article  Google Scholar 

Brachman RA, McGowan JC, Perusini JN, Lim SC, Pham TH, Faye C et al (2016) Ketamine as a prophylactic against stress-induced depressive-like behavior. Biol Psychiat 79(9):776–786

Article  CAS  PubMed  Google Scholar 

DePierro J, Lepow L, Feder A, Yehuda R (2019) Translating molecular and neuroendocrine findings in posttraumatic stress disorder and resilience to novel therapies. Biol Psychiat 86(6):454–463

Article  CAS  PubMed  Google Scholar 

Holman MS, Williams MN (2022) Suicide risk and protective factors: a network approach. Arch Suicide Res 26(1):137–154

Article  PubMed  Google Scholar 

Wang C, Zhou Y, Zheng W, Liu W, Zhan Y, Li H et al (2019) Association between depression subtypes and response to repeated-dose intravenous ketamine. Acta Psychiatr Scand 140(5):446–457

Article  CAS  PubMed  Google Scholar 

Dold M, Bartova L, Fugger G, Kautzky A, Souery D, Mendlewicz J et al (2018) Major depression and the degree of suicidality: results of the European Group for the Study of Resistant Depression (GSRD). Int J Neuropsychopharmacol 21(6):539–549

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su TP, Li CT, Lin WC, Wu HJ, Tsai SJ, Bai YM et al (2023) A randomized double-blind midazolam-controlled trial of low-dose ketamine infusion in patients with treatment-resistant depression and prominent suicidal ideation. Int J Neuropsychopharmacol. https://doi.org/10.1093/ijnp/pyad014

Article  PubMed  PubMed Central  Google Scholar 

Su TP, Chen MH, Li CT, Lin WC, Hong CJ, Gueorguieva R et al (2017) Dose-related effects of adjunctive ketamine in Taiwanese patients with treatment-resistant depression. Neuropsychopharmacology 42(13):2482–2492

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carmody TJ, Rush AJ, Bernstein I, Warden D, Brannan S, Burnham D et al (2006) The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol 16(8):601–611

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grunebaum MF, Galfalvy HC, Choo TH, Keilp JG, Moitra VK, Parris MS et al (2018) Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry 175(4):327–335

Article  PubMed  Google Scholar 

Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM et al (2013) Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 170(10):1134–1142

Article  PubMed  PubMed Central  Google Scholar 

Osman A, Gutierrez PM, Kopper BA, Barrios FX, Chiros CE (1998) The positive and negative suicide ideation inventory: development and validation. Psychol Rep 82(3 Pt 1):783–793

Article  CAS  PubMed  Google Scholar 

Wilkinson ST, Ballard ED, Bloch MH, Mathew SJ, Murrough JW, Feder A et al (2018) The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry 175(2):150–158

Article  PubMed  Google Scholar 

Fekadu A, Wooderson SC, Markopoulou K, Cleare AJ (2009) The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms. J Clin Psychiatry 70(7):952–957

Article  PubMed  Google Scholar 

Bech P, Gram L, Dein E, Jacobsen O, Vitger J, Bolwig T (1975) Quantitative rating of depressive states: correlation between clinical assessment, Beck’s self-rating scale and Hamilton’s objective rating scale. Acta Psychiatr Scand 51(3):161–170

Article  CAS  PubMed  Google Scholar 

PrimodeCarvalho Alves L, PiodeAlmeida Fleck M, Boni A, Sicada RN (2017) The major depressive disorder hierarchy: Rasch analysis of 6 items of the Hamilton depression scale covering the continuum of depressive syndrome. PLoS ONE 12(1):e0170000

Article  Google Scholar 

Østergaard SD, Bech P, Trivedi MH, Wisniewski SR, Rush AJ, Fava M (2014) Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: implications for the research domain criteria (RDoC). J Affect Disord 163:18–24

Article  PubMed  Google Scholar 

Grunebaum MF, Galfalvy HC, Oquendo MA, Burke AK, Mann JJ (2004) Melancholia and the probability and lethality of suicide attempts. Br J Psychiatry 184:534–535

Article  PubMed  Google Scholar 

Weissman CR, Hadas I, Yu D, Jones B, Kong D, Mulsant BH et al (2021) Predictors of change in suicidal ideation across treatment phases of major depressive disorder: analysis of the STAR*D data. Neuropsychopharmacology 46(7):1293–1299

Article  PubMed  PubMed Central  Google Scholar 

Zisook S, Trivedi MH, Warden D, Lebowitz B, Thase ME, Stewart JW et al (2009) Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. J Affect Disord 117(1–2):63–73

Article  PubMed  Google Scholar 

Chen MH, Lin WC, Wu HJ, Bai YM, Li CT, Tsai SJ et al (2020) Happiness during low-dose ketamine infusion predicts treatment response: reexploring the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression. J Clin Psychiatry. https://doi.org/10.4088/JCP.20m13232

Article  PubMed  Google Scholar 

Gaydos SJ, Kelley AM, Grandizio CM, Athy JR, Walters PL (2015) Comparison of the effects of ketamine and morphine on performance of representative military tasks. J Emerg Med 48(3):313–324

Article  PubMed  Google Scholar 

Dwivedi Y (2010) Brain-derived neurotrophic factor and suicide pathogenesis. Ann Med 42(2):87–96

Article  PubMed  Google Scholar 

Sonal A, Raghavan V (2018) Brain derived neurotrophic factor (BDNF) and suicidal behavior: a review of studies from Asian countries. Asian J Psychiatr 33:128–132

Article  PubMed  Google Scholar 

Kudinova AY, Deak T, Deak MM, Gibb BE (2019) Circulating levels of brain-derived neurotrophic factor and history of suicide attempts in women. Suicide Life Threat Behav 49(1):54–63

Article  PubMed  Google Scholar 

Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R (2005) Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 136(1–2):29–37

Article  CAS  PubMed  Google Scholar 

Kavalali ET, Monteggia LM (2012) Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry 169(11):1150–1156

Article  PubMed  Google Scholar 

Zanos P, Gould TD (2018) Mechanisms of ketamine action as an antidepressant. Mol Psychiatry 23(4):801–811

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taliaz D, Loya A, Gersner R, Haramati S, Chen A, Zangen A (2011) Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J Neurosci 31(12):4475–4483

Article  CAS  PubMed  PubMed Central  Google Scholar